<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Yersiniosis: Infection due to Yersinia enterocolitica and Yersinia pseudotuberculosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Yersiniosis: Infection due to Yersinia enterocolitica and Yersinia pseudotuberculosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Yersiniosis: Infection due to Yersinia enterocolitica and Yersinia pseudotuberculosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert V Tauxe, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 10, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The yersinioses are zoonotic infections of domestic and wild animals; humans are incidental hosts that do not contribute to the natural disease cycle. Three species are important human pathogens: <em>Yersinia pestis</em>, <em>Yersinia enterocolitica</em>, and <em>Yersinia pseudotuberculosis </em>[<a href="#rid1">1</a>]. </p><p><em>Y. enterocolitica</em> and <em>Y. pseudotuberculosis</em> cause yersiniosis, a diarrheal illness; this condition is discussed below.</p><p><em>Y. pestis</em> causes plague; this condition is discussed separately. (See  <a class="medical medical_review" href="/d/html/3143.html" rel="external">"Epidemiology, microbiology and pathogenesis of plague (<i>Yersinia pestis</i> infection)"</a> and  <a class="medical medical_review" href="/d/html/3131.html" rel="external">"Clinical manifestations, diagnosis, and treatment of plague (<i>Yersinia pestis</i> infection)"</a>.)</p><p class="headingAnchor" id="H2733178561"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H362416409"><span class="h2">Reservoirs of infection</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Y. enterocolitica</em></strong> – <em>Y. enterocolitica</em> strains have been isolated from a variety of vertebrate hosts, including domesticated animals as well as wildlife [<a href="#rid2">2</a>]. In pigs, the organism colonizes the tonsils and other oropharyngeal lymphoid tissues; from these sites, it can be shed into the gastrointestinal tract. Healthy pigs are frequently colonized with strains that cause human illness, such as serotype O:3 and serotype O:9. </p><p></p><p class="bulletIndent1"><em>Y. enterocolitica</em> in swine herds may spread as pigs are transferred from one farm to another and then can persist on a farm for many years [<a href="#rid3">3</a>]. The organisms can contaminate retail pork products, including neck trimmings, tonsillar tissue, tongue, and tripe, and can be transferred to other cuts of meat during slaughter [<a href="#rid4">4,5</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Y. pseudotuberculosis</em></strong><em> </em>–<em> Y. pseudotuberculosis</em> has been isolated from a variety of mammals and birds. It causes epizootic disease in northern Europe among European brown hares, in Australia among sheep, and in New Zealand among farmed deer [<a href="#rid6">6-8</a>].</p><p></p><p class="headingAnchor" id="H2479403085"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Transmission of yersiniosis is largely foodborne (including pork and other food sources) and occasionally waterborne. Uncommon modes of transmission include exposure to household pets [<a href="#rid9">9</a>], person-to-person fecal-oral transmission [<a href="#rid10">10</a>], and transfusion of blood products [<a href="#rid11">11,12</a>].</p><p>Updated information on outbreaks may be found on websites maintained by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ffoodnet%2Freports%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLP%2F2QvaEIA4SKO0gOEuf1VgY0YkeS8eQxq4ypPiI8NSzyeT%2FmnPtuFxMsoc8brVKag%3D%3D&amp;TOPIC_ID=3139" target="_blank">United States Centers for Disease Control and Prevention</a> and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Frecalls-outbreaks-emergencies%2Foutbreaks-foodborne-illness&amp;token=RnGqCfYGTGgdz5387EFWwvy4g0FBsVH2%2F8GNTYjMB5LrJLowNdHBE3AHH5VQdHvjZEGstInrU%2FzZFkdijUOFBBVMo%2FciHvaLQZ9RU37rpBQ%3D&amp;TOPIC_ID=3139" target="_blank">US Food and Drug Administration</a>.</p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Y. enterocolitica</em></strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pork and other food sources </strong>– Consumption of raw or undercooked pork products is a major mode of transmission for <em>Y. enterocolitica</em>. Case-control studies of sporadic illnesses in Belgium and Norway have noted a strong association between consumption of undercooked or raw pork products and yersiniosis [<a href="#rid13">13,14</a>]. In a Swedish study, strains of <em>Y. enterocolitica</em> isolated from retail pork had the same PFGE profiles as patient isolates [<a href="#rid15">15</a>]. In Norway and New Zealand, sporadic yersiniosis has been associated with drinking untreated surface water [<a href="#rid14">14,16</a>].</p><p></p><p class="bulletIndent2">Yersiniosis has been associated with preparation of chitterlings, a winter holiday dish comprised of pig intestines [<a href="#rid17">17-20</a>]. This was first described in 1989 during an investigation of bacteremia among bottle-fed African American infants in the United States; transmission was attributed to cross contamination of infant bottles or formula during chitterling preparation [<a href="#rid18">18</a>]. </p><p></p><p class="bulletIndent2">Outbreaks have been attributed to other food sources [<a href="#rid21">21-25</a>], including tofu packaged in untreated spring water [<a href="#rid21">21</a>], contamination of salad greens, and post-pasteurization contamination of milk [<a href="#rid22">22-27</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Blood transfusion</strong> – In rare cases, <em>Y. enterocolitica</em> septicemia has occurred following transfusion with packed red cells [<a href="#rid11">11</a>]. <em>Yersinia</em> organisms are ferrophilic and capable of multiplying slowly in stored units of red cells at cold temperatures prior to transfusion. In one study conducted between 1998 and 2000, the incidence of transfusion-associated <em>Yersinia</em> sepsis was 1 in 23.7 million red cell transfusions [<a href="#rid28">28</a>]. (See <a class="local">'Microbiology'</a> below and  <a class="medical medical_review" href="/d/html/3805.html" rel="external">"Transfusion-transmitted bacterial infection", section on 'Reducing risk of bacteria in the product'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Y. pseudotuberculosis</em></strong><strong> </strong>– Data on transmission of <em>Y. pseudotuberculosis</em> are limited; outbreaks have been associated with consumption of contaminated lettuce, carrots, and milk [<a href="#rid29">29-33</a>].</p><p></p><p class="headingAnchor" id="H1392465132"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Individuals at increased risk for yersiniosis include: </p><p class="bulletIndent1"><span class="glyph">●</span>Children &lt;5 years of age, especially &lt;12 months of age.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with derangements of iron metabolism (such as cirrhosis, hemochromatosis, aplastic anemia, thalassemia, sickle cell disease, and iron overload) — <em>Yersinia</em> organisms are ferrophilic, and patients who undergo transfusion can develop iron overload. However, in one series of patients with thalassemia, yersiniosis was observed even among individuals whose iron burden was not greatly elevated; the reasons for this observation are not fully understood [<a href="#rid34">34</a>]. (See <a class="local">'Microbiology'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with other comorbid conditions (such as immunosuppression, malignancy, diabetes, or severe malnutrition). </p><p></p><p>Individuals with relevant exposure risks (consumption of uncooked or raw pork products, exposure to other food sources or untreated water, or blood transfusion) are also at risk for yersiniosis. (See <a class="local">'Transmission'</a> above.)</p><p class="headingAnchor" id="H3619244697"><span class="h2">Disease incidence</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Geographic distribution</strong> – Yersiniosis has been reported frequently in northern Europe, particularly in Belgium, Norway, and the Netherlands; it is rarely observed in tropical countries [<a href="#rid35">35</a>]. The reasons for these geographic patterns are uncertain but may reflect the frequency of infection in food animal reservoirs.</p><p></p><p class="bulletIndent1">In Europe, the annual incidence in 2016 was 1.8 cases per 100,000; the incidence was highest in Finland (7.4 per 100,000) and Lithuania (5.9 per 100,000) [<a href="#rid36">36</a>]. In Belgium, the incidence peaked in 1986 at 14.7 per 100,000; in 2016 it was 3.1 per 100,000 [<a href="#rid35">35,37</a>]. Reasons for declining incidence may include public education to reduce consumption of raw or undercooked pork products, changing dietary habits, and efforts by the meat industry to reduce contamination of carcasses during processing [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1">In the United States, the incidence of yersiniosis is lower than in Europe. The incidence of yersiniosis reported to the Foodborne Disease Active Surveillance program (FoodNet) of the United States Centers for Disease Control and Prevention (CDC) was higher in 2022 compared with 2016 to 2018 (2.0 versus 0.9 per 100,000) [<a href="#rid39">39</a>]. This increase likely reflects the greater frequency of testing with rapid culture-independent diagnostic tests (CIDTs) [<a href="#rid40">40</a>]. Almost all yersiniosis in the United States is due to <em>Y. enterocolitica</em>; between 1996 and 2007, only 1 percent of reported yersiniosis was due to <em>Y. pseudotuberculosis</em> [<a href="#rid41">41</a>]. Accounting for underdiagnosis and under-reporting, the actual number of <em>Y. enterocolitica </em>infections occurring annually in the United States is estimated to be 117,000 [<a href="#rid42">42</a>]. </p><p></p><p class="bulletIndent1">In New Zealand, high rates of <em>Y. enterocolitica</em> infection have been described since the 1990s; in 2019 the incidence was 24.1 per 100,000 [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence among children</strong> – The incidence of <em>Yersinia</em> infections is highest among young children, although the age distribution may be changing in the era of multipathogen syndromic diagnostic panels. </p><p></p><p class="bulletIndent1">In Europe, in 2016, the incidence among children &lt;5 years of age was 7.5 per 100,000 [<a href="#rid36">36</a>]. </p><p></p><p class="bulletIndent1">In the United States between 1996 and 2009, children &lt;5 years of age comprised 47 percent of <em>Yersinia</em> infections reported to the CDC's FoodNet program [<a href="#rid44">44</a>]. Over this time, the overall incidence among children dropped from 9.2 to 1.9 per 100,000, and the most substantial decrease was among African American children &lt;5 years of age, in whom the incidence dropped from 41.5 to 3.5 per 100,000 cases [<a href="#rid44">44</a>]. </p><p></p><p class="headingAnchor" id="H1440640136"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>Yersinia</em> are facultative gram-negative anaerobic coccobacilli [<a href="#rid45">45,46</a>]. <em>Y. pseudotuberculosis</em> and <em>Y. enterocolitica</em> are bile tolerant and grow on MacConkey agar, they ferment glucose but not lactose, they are oxidase negative, and reduce nitrate to nitrite. </p><p><em>Y. pseudotuberculosis</em> and <em>Y. enterocolitica</em> are readily differentiated by biochemical tests. <em>Yersinia</em> can also be biotyped (by a combination of phenotypic markers) and serotyped (using antisera produced against cell surface lipopolysaccharide antigens, known classically as the O antigens) [<a href="#rid47">47,48</a>]. For <em>Y. enterocolitica</em>, biotype and serotype are correlated; the most common are serotype O:9 biotype 2, serotype O:3 biotype 4, and serotype O:8 biotype 1B [<a href="#rid49">49</a>]. Both species can be further subtyped using molecular methods. Biotype and serotype are useful epidemiologic tools that can provide clues to the environmental source of an infection [<a href="#rid2">2</a>]. Detecting a cluster of infections of the same molecular subtype may indicate that the cases are linked to a common source. </p><p>Noteworthy microbiological features of <em>Y. enterocolitica</em> include: </p><p class="bulletIndent1"><span class="glyph">●</span>The organism is cryophilic; on suitable media, it is capable of multiplying at refrigerator temperatures (2 to 4°C), although its optimal growth temperature is 25 to 28°C. (See <a class="local">'Organism identification'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most strains lack efficient intrinsic iron uptake mechanisms; they depend on the iron binding strategies of other bacteria to capture the iron they need [<a href="#rid50">50</a>]. Clinical conditions associated with iron-overload such as chronic liver disease, hemochromatosis, and thalassemias have been associated with an increased risk of invasive yersiniosis [<a href="#rid51">51</a>]. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Many virulent strains are relatively calcium dependent, and require calcium-supplemented medium to grow at 37°C. </p><p></p><p>Certain subtypes of <em>Y. enterocolitica</em> are virulent for humans [<a href="#rid52">52</a>]. The most important human pathogens are serogroups O:3, O:5,27, O:8, and O:9 though other serogroups may occasionally cause infection. Isolation of non-virulent types from a non-sterile body site is likely to be an incidental finding. Rapid tests can determine whether an isolate is likely to be pathogenic. (See <a class="local">'Organism identification'</a> below.) </p><p class="headingAnchor" id="H5495536"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Major clinical manifestations include acute yersiniosis (eg, acute febrile enterocolitis) and pseudoappendicitis syndrome. A variety of complications (both gastrointestinal and extraintestinal) and post-infectious sequelae have also been described, as outlined in the following sections [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H89479838"><span class="h2">Acute yersiniosis</span><span class="headingEndMark"> — </span>The typical incubation period for acute yersiniosis is 4 to 6 days (range 1 to 14 days) [<a href="#rid18">18,21,54</a>]. </p><p class="headingAnchor" id="H815690183"><span class="h3">Enterocolitis</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General signs and symptoms</strong> – Clinical manifestations include fever, abdominal pain, and diarrhea; nausea and vomiting may also occur [<a href="#rid55">55</a>]. </p><p></p><p class="bulletIndent1">The onset of <em>Yersinia </em>enterocolitis can be more subacute than other diarrheal pathogens [<a href="#rid13">13,56</a>]. In a Norwegian study including 67 cases of sporadic yersiniosis, an average of more than a week elapsed before patients sought medical care and almost two weeks elapsed before a stool culture was obtained [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent1">The median duration of diarrhea for yersiniosis can be longer than for other causes of acute enterocolitis. In four case series, the duration ranged from 12 to 22 days  (<a class="graphic graphic_table graphicRef73764" href="/d/graphic/73764.html" rel="external">table 1</a>) [<a href="#rid13">13,56-59</a>]. Prolonged illnesses were observed in each case series, and some patients reported persistent diarrhea or abdominal pain up to a year following acute illness. </p><p></p><p class="bulletIndent1">In some circumstances, localization of abdominal pain to the right lower quadrant may be a diagnostic clue for yersiniosis. (See <a class="local">'Pseudoappendicitis'</a> below.) </p><p></p><p class="bulletIndent1">Following <em>Yersinia</em> enterocolitis, stool shedding of organisms may persist after resolution of diarrhea. Among 67 patients with yersiniosis in Norway, shedding was observed among 47 percent of cases and lasted a median of 40 days (range 17 to 116 days) after illness onset [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manifestations in children</strong> – Among children &lt;5 years, the most prominent clinical manifestations are fever, diarrhea, and vomiting; abdominal pain is observed relatively infrequently [<a href="#rid60">60</a>]. In more severe infections, leukocytosis is often observed [<a href="#rid17">17</a>]. </p><p></p><p class="bulletIndent1">Bloody diarrhea is observed more frequently among children than adults. In case series of mainly pediatric patients, 20 to 60 percent reported bloody diarrhea  (<a class="graphic graphic_table graphicRef73764" href="/d/graphic/73764.html" rel="external">table 1</a>) [<a href="#rid18">18,21,22</a>]. In contrast, in a series of 29 adults with yersiniosis, bloody diarrhea was noted in only 7 percent of cases [<a href="#rid59">59</a>]. </p><p></p><p class="bulletIndent1">The above features may be clinical clues for distinguishing from infection with Shiga toxin producing <em>Escherichia coli</em> (STEC), such as <em>E. coli</em> O157:H7, which may present with bloody stools, pronounced abdominal pain, and minimal fever. (See  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment"</a>.)</p><p></p><p class="headingAnchor" id="H3376882018"><span class="h3">Pharyngitis</span><span class="headingEndMark"> — </span>Pharyngitis may also be a presenting symptom in patients with acute yersiniosis. In some case series, sore throat was reported by up to 20 percent of patients  (<a class="graphic graphic_table graphicRef73764" href="/d/graphic/73764.html" rel="external">table 1</a>) [<a href="#rid13">13,22,56,61</a>]. In one outbreak, <em>Y. enterocolitica</em> was isolated from throat cultures in 14 patients, illustrating the propensity for involvement of lymphoid tissue, such as the tonsils (in humans as well as pigs) [<a href="#rid61">61</a>]. This symptom can be a helpful diagnostic clue since other causes of acute bacterial diarrhea are not associated with pharyngitis. (See <a class="local">'Reservoirs of infection'</a> above.)</p><p>In Eastern Siberia and Japan, a scarlet-fever like syndrome associated with <em>Y. pseudotuberculosis</em> has been described; this is characterized by fever, systemic illness, arthralgias, and a presence of a morbilliform or confluently erythematous rash that subsequently desquamates [<a href="#rid62">62</a>].</p><p class="headingAnchor" id="H419216027"><span class="h3">Bacteremia and sepsis</span><span class="headingEndMark"> — </span><em>Yersinia </em>septicemia can occur in the setting of acute infection, particularly among infants and individuals with impaired immunity or iron-overload states [<a href="#rid63">63,64</a>]. In addition, transient bacteremia may be more common than previously recognized, even among otherwise healthy individuals [<a href="#rid11">11</a>]. In one report of 55 cases associated with blood transfusion, rapid onset septic shock was described with an overall fatality of 50 percent [<a href="#rid12">12</a>]. (See <a class="local">'Risk factors'</a> above.)</p><p class="headingAnchor" id="H89479916"><span class="h2">Pseudoappendicitis</span><span class="headingEndMark"> — </span>Acute yersiniosis may be confused with acute appendicitis; overlapping symptoms may include right lower quadrant abdominal pain, fever, vomiting, leukocytosis, and diarrhea. </p><p>For patients who undergo surgery, operative findings include inflammation around the appendix, terminal ileum, and mesenteric lymph nodes; the appendix itself is generally normal. <em>Yersinia</em> can be cultured from the appendix and involved lymph nodes [<a href="#rid65">65</a>]. </p><p>One outbreak of yersiniosis among children was identified because of an unusually high number of cases of suspected appendicitis; approximately 42 percent of identified cases underwent surgery [<a href="#rid66">66</a>]. In other outbreaks, the rates of surgical intervention have ranged from 0 to 14 percent  (<a class="graphic graphic_table graphicRef73764" href="/d/graphic/73764.html" rel="external">table 1</a>) [<a href="#rid18">18,21,22</a>]. </p><p>In regions where the incidence of yersiniosis is high, an appreciable fraction of appendectomies occurs in the setting of yersiniosis [<a href="#rid67">67-69</a>]. In one study including 2861 patients in Belgium who underwent appendectomy for clinically suspected appendicitis, pathogenic <em>Y. enterocolitica</em> was cultured from the appendix in 3.6 percent of cases; among 73 patients with a positive appendix culture, gross examination demonstrated mesenteric adenitis and/or terminal ileitis (rather than frank appendicitis) in 75 percent of cases [<a href="#rid68">68</a>]. </p><p class="headingAnchor" id="H5496437"><span class="h2">Complications</span><span class="headingEndMark"> — </span>Gastrointestinal complications of acute yersiniosis are rare; they include [<a href="#rid54">54,70-76</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse ulcerating ileitis and colitis</p><p class="bulletIndent1"><span class="glyph">●</span>Intestinal perforation</p><p class="bulletIndent1"><span class="glyph">●</span>Peritonitis</p><p class="bulletIndent1"><span class="glyph">●</span>Intussusception</p><p class="bulletIndent1"><span class="glyph">●</span>Paralytic ileus</p><p class="bulletIndent1"><span class="glyph">●</span>Toxic megacolon</p><p class="bulletIndent1"><span class="glyph">●</span>Necrotic small bowel</p><p class="bulletIndent1"><span class="glyph">●</span>Cholangitis</p><p class="bulletIndent1"><span class="glyph">●</span>Mesenteric vein thrombosis</p><p></p><p>Extraintestinal complications of acute yersiniosis are also rare; they include [<a href="#rid54">54,70-76</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Abscess of the liver, spleen, kidney or lung </p><p class="bulletIndent1"><span class="glyph">●</span>Pharyngeal abscess</p><p class="bulletIndent1"><span class="glyph">●</span>Empyema</p><p class="bulletIndent1"><span class="glyph">●</span>Endocarditis</p><p class="bulletIndent1"><span class="glyph">●</span>Mycotic aneurysm</p><p class="bulletIndent1"><span class="glyph">●</span>Meningitis</p><p class="bulletIndent1"><span class="glyph">●</span>Ophthalmitis</p><p class="bulletIndent1"><span class="glyph">●</span>Osteomyelitis</p><p class="bulletIndent1"><span class="glyph">●</span>Septic arthritis</p><p class="bulletIndent1"><span class="glyph">●</span>Suppurative lymphadenitis</p><p class="bulletIndent1"><span class="glyph">●</span>Skin manifestations (carbuncle, granuloma, vesiculobullous lesions, pustules, wound infection)</p><p></p><p>Myocarditis, glomerulonephritis, and liver failure have all been reported following yersiniosis; these are extremely rare.</p><p class="headingAnchor" id="H10"><span class="h2">Post-infectious sequelae</span><span class="headingEndMark"> — </span>The most common post-infectious sequelae are erythema nodosum and reactive arthritis; these are particularly common in northern Europe, especially among those with the HLA-B27 tissue type [<a href="#rid77">77</a>]. </p><p>Erythema nodosum has been observed to occur following acute <em>Yersinia</em> infection in up to 30 percent of patients in Finland, particularly among young women; it is less frequently recognized elsewhere [<a href="#rid78">78</a>]. It typically occurs within one month after acute infection and is self-limited. (See  <a class="medical medical_review" href="/d/html/5612.html" rel="external">"Erythema nodosum"</a>.) </p><p>Reactive arthropathy has been described in up to 30 percent of adults affected in an outbreak of <em>Y. pseudotuberculosis</em> infections in Finland; most patients had HLA-B27 tissue type [<a href="#rid79">79</a>]. Reactive arthritis typically affects the large weight-bearing joints and begins several weeks after the onset of acute infection. Symptoms can be self-limited (lasting three to five months) or can persist with a relapsing pattern [<a href="#rid53">53</a>]. In a ten-year follow-up study of Finnish patients with reactive arthritis, 52 percent reported mild peripheral joint symptoms, 36 percent reported chronic low back pain, and 36 percent had radiographic evidence of sacroiliitis [<a href="#rid80">80</a>]. (See  <a class="medical medical_review" href="/d/html/7794.html" rel="external">"Reactive arthritis"</a>.)</p><p>Ocular involvement including conjunctivitis and uveitis has also been described [<a href="#rid81">81</a>].</p><p>The time course of these complications mirrors the humoral immune response to bacterial infections. The pathogenesis of reactive arthropathy reflects "molecular mimicry" (eg, the antigenic similarity of <em>Yersinia</em> antigens to antigens in the joints of susceptible individuals). The immune response to <em>Yersinia</em> antigens can cross-react against host antigens. Some studies have identified <em>Yersinia</em>-like antigens in synovial fluid, although it is unlikely that these reflect microbial growth in joints [<a href="#rid82">82,83</a>]. </p><p><em>Yersinia</em> also shares an antigen with thyroid tissue that resembles the thyrotropin (TSH) binding site. Therefore, individuals with Graves' disease may have antibodies that cross react with <em>Yersinia</em> [<a href="#rid84">84</a>]. However, there is no evidence that yersiniosis actually triggers thyroiditis [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3671963746"><span class="h2">Clinical approach</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical suspicion</strong> – Yersiniosis should be suspected in the setting of relevant clinical manifestations (fever, abdominal pain, and diarrhea, with or without nausea and vomiting). These manifestations may occur in the presence or absence of relevant epidemiologic exposure (such as consumption of raw or undercooked pork or exposure to food or water implicated in an outbreak). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – Patients with enterocolitis should have stool sent for culture. If available, stool may also be sent for rapid molecular panel testing; such panels may facilitate diagnosis of yersiniosis but are not able to assess antimicrobial susceptibility. If <em>Yersinia</em> is identified via molecular testing, reflex culture and susceptibility testing should be performed. (See <a class="local">'Organism identification'</a> below.)</p><p></p><p class="bulletIndent1">Patients with fever should have blood cultures obtained. Patients with pharyngitis should have a throat culture obtained. In infants with yersiniosis, cerebrospinal fluid should be examined in infants [<a href="#rid85">85</a>]. </p><p></p><p class="bulletIndent1">For patients who undergo surgery in the setting of suspected appendicitis, specimens of appendix or mesenteric lymph nodes obtained operatively should be cultured. </p><p></p><p class="bulletIndent1">For clinical circumstances in which abscess material, pleural fluid, or other focal suppurative samples are obtained, these should be cultured as well. </p><p></p><p class="headingAnchor" id="H3503691495"><span class="h2">Organism identification</span><span class="headingEndMark"> — </span>The diagnosis of <em>Yersinia</em> infection is usually established by culture of the organism from stool or blood; it may also be established by culture from the throat, appendix, mesenteric lymph nodes, or other sterile sites [<a href="#rid2">2</a>]. Specimens that test positive via culture-independent techniques should be set up for reflex culture and susceptibility testing [<a href="#rid86">86</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Culture</strong> – Most laboratories do not screen for <em>Yersinia</em> species routinely on stool culture. <em>Yersinia</em> species grow poorly on the agars commonly used for the isolation of stool pathogens [<a href="#rid48">48</a>]. The organisms do grow well on MacConkey agar; however, at routine incubation temperatures, they form small colorless lactose-negative colonies, which are easily overlooked by the inexperienced eye unless the plates are examined for them specifically [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1">The most widely studied selective growth medium is cefsulodin-irgasin-novobiocin (CIN) agar, which inhibits the growth of competing flora and produces a characteristic colony morphology  (<a class="graphic graphic_figure graphicRef64722" href="/d/graphic/64722.html" rel="external">figure 1</a>) [<a href="#rid87">87</a>]. <em>If Yersinia</em> culture is requested, the laboratory usually will use CIN media or reincubate the original MacConkey agar culture. CHROMag<em>ar Yersinia</em> has been reported to be more selective for pathogenic strains <em>of Y. enterocolitica</em>, b<em>ut Y. pseudotuberculosis </em>does not grow on it at all [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent1">The optimal growth temperature for<em> Yersinia</em> species is 25 to 28°C; this condition also inhibits growth of other organisms, even on non-selective MacConkey agar. At this temperature,<em> Yersinia</em> species can be isolated within 24 to 48 hours. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Culture-independent tests</strong> – Evaluating the performance of culture-independent tests for detection of <em>Y. enterocolitica</em> is challenging given the rarity of infection. Two multiplex platforms showed sensitivity of 48 to 100 percent and specificity of 99.6 to 100 percent [<a href="#rid89">89</a>]. </p><p></p><p class="bulletIndent1">Specimens that test positive by culture-independent tools should be set up for reflex culture to secure the diagnosis, obtain antimicrobial susceptibility, and to strengthen public health surveillance [<a href="#rid86">86,90</a>]. </p><p></p><p class="bulletIndent1">Multiplex panels do not usually include <em>Y. pseudotuberculosis </em>targets.</p><p></p><p class="headingAnchor" id="H3527278671"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other causes of diarrhea</strong> – The differential diagnosis for <em>Yersinia</em> infection includes infection with <em>Salmonella</em>, <em>Campylobacter</em>, <em>Shigella</em>, enteroinvasive <em>E. coli</em>, <em>E. histolytica</em>, or <em>Clostridioides</em> <em>difficile</em>, as well as noninfectious inflammatory bowel disease. (See  <a class="medical medical_review" href="/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/d/html/6456.html" rel="external">"Diagnostic approach to diarrhea in children in resource-abundant settings"</a> and  <a class="medical medical_review" href="/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudoappendicitis</strong> – <em>Campylobacter</em> infection may also present with pseudoappendicitis. The differential diagnosis of appendicitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/2715.html" rel="external">"Campylobacter infection: Clinical manifestations, diagnosis, and treatment", section on 'Pseudoappendicitis'</a> and  <a class="medical medical_review" href="/d/html/1386.html" rel="external">"Acute appendicitis in adults: Clinical manifestations and differential diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3100443790"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H250543031"><span class="h2">Antibiotic susceptibility</span><span class="headingEndMark"> — </span>The <em>Y. enterocolitica</em> serotype most commonly associated with clinical illness (O:3) usually produces chromosomally-mediated beta-lactamases and thus is resistant to penicillin, <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>, and most first generation cephalosporins [<a href="#rid2">2,91</a>]. In addition, <em>Yersinia</em> is usually resistant to macrolides.</p><p>Clinical strains are usually susceptible to other beta-lactam agents including cephalosporins (second, third, or fourth generation), fluoroquinolones, aminoglycosides, tetracyclines, <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, and <a class="drug drug_general" data-topicid="9241" href="/d/drug information/9241.html" rel="external">chloramphenicol</a> [<a href="#rid92">92</a>]. In one series, strains were uniformly susceptible to <a class="drug drug_general" data-topicid="9775" href="/d/drug information/9775.html" rel="external">piperacillin</a>, <a class="drug drug_general" data-topicid="8553" href="/d/drug information/8553.html" rel="external">imipenem</a>, <a class="drug drug_general" data-topicid="9226" href="/d/drug information/9226.html" rel="external">ceftazidime</a>, <a class="drug drug_general" data-topicid="9215" href="/d/drug information/9215.html" rel="external">cefepime</a>, aminoglycosides, fluoroquinolones, and trimethoprim-sulfamethoxazole [<a href="#rid93">93</a>].</p><p>Quinolone resistance, including resistance to nalidixic acid and reduced susceptibility to <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a>, has been reported in Spain [<a href="#rid94">94,95</a>]. As person-to-person transmission of <em>Y. enterocolitica</em> is rare, this is likely attributable to use of antimicrobials in agriculture.</p><p class="headingAnchor" id="H1902716699"><span class="h2">Clinical approach</span></p><p class="headingAnchor" id="H268515570"><span class="h3">Nonsevere enterocolitis</span></p><p><strong>Indications </strong>–<strong> </strong>For patients with mild enterocolitis in the absence of risk for severe illness, antibiotic therapy is not warranted, given lack of benefit. Maintenance of proper hydration and correction of electrolyte abnormalities should be the focus of therapy. </p><p class="bulletIndent1">For patients with nonsevere enterocolitis who are neonates, or who have underlying immunosuppression or derangement of iron metabolism, we favor treatment with oral antibiotic therapy. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rationale</strong> – No clinical data have demonstrated benefit to antimicrobial therapy for treatment of yersiniosis. In two trials of antimicrobial therapy for yersiniosis (one among 34 children in Canada with <em>Y. enterocolitica</em> infection treated with <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, and another among 136 children in Japan with <em>Y. pseudotuberculosis</em> infection treated with <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>), treatment was not associated with clinical benefit in either group [<a href="#rid96">96,97</a>]. </p><p></p><p class="bulletIndent1">Similarly, in a retrospective case series among 67 adults in Norway with <em>Y. enterocolitica</em> enterocolitis (67 case-patients and 132 controls), the duration of illness was comparable between the groups (18 versus 21 days) [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent1">In addition, no clinical data have demonstrated any association between early antimicrobial therapy and the frequency or severity of chronic sequelae for infection due to <em>Y. enterocolitica</em> or <em>Y. pseudotuberculosis</em> [<a href="#rid98">98,99</a>].</p><p></p><p class="bulletIndent1">Antimicrobial treatment has been associated with a reduction in stool shedding [<a href="#rid56">56,96,97</a>]; however, this is not an indication for treatment since person-to-person transmission of <em>Yersinia</em> infection is rare [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antibiotic selection and duration</strong> – For treatment of adults with nonsevere enterocolitis, when indicated, we use a fluoroquinolone (such as <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> 500 mg orally twice daily or <a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">levofloxacin</a> 500 mg orally once daily). Alternative agents include <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a> or <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> [<a href="#rid54">54</a>]. </p><p></p><p class="bulletIndent1">For treatment of children with nonsevere enterocolitis, when indicated, we use <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (TMP 8 mg/kg per day and SMX 40 mg/kg per day in two divided doses).</p><p></p><p class="bulletIndent1">Antibiotic therapy should be tailored to susceptibility data when available. The usual treatment duration is five days.</p><p></p><p class="headingAnchor" id="H1229269418"><span class="h3">Severe illness</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – For patients with bacteremia, sepsis, or severe illness (grossly bloody stools and high fever, other manifestations of extraintestinal infection), we favor treatment with intravenous antibiotic therapy [<a href="#rid54">54</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antibiotic selection and duration</strong> – We use a third-generation cephalosporin such as <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> (adults: 2 g IV once daily; children: 100 mg/kg per day in one or two divided doses, to a maximum dose of 4 g per day), combined with <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a> (adults: 5 mg/kg per day in one to three divided doses). An alternative to ceftriaxone is <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> (adults: 400 mg IV twice daily), if susceptible. In children, the benefit of ciprofloxacin should be weighed against risk of side effects [<a href="#rid100">100</a>]. </p><p></p><p class="bulletIndent1">Antibiotic therapy should be tailored to susceptibility data as soon as it is available. </p><p></p><p class="bulletIndent1">We administer treatment in patients with severe illness for at least three weeks; a longer duration may be appropriate for patients with compromised immunity or focal extraintestinal infection. Once clinically improved, the patient can be switched to oral treatment to complete therapy [<a href="#rid63">63,70</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rationale</strong> – Clinical data for treatment of <em>Yersinia</em> bacteremia or sepsis are limited. In a retrospective case series of 43 patients with <em>Y. enterocolitica</em> septicemia, third generation cephalosporins (with or without other antibiotics) were effective in 85 percent of cases; fluoroquinolones (alone or in combination), cured all of 15 infections [<a href="#rid63">63</a>]. Agents that were ineffective when used as monotherapy included <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>, <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a>, first-generation cephalosporins, and <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>. The duration of therapy varied from two to six weeks, with a median of 22 days (intravenous followed by oral therapy).</p><p></p><p class="headingAnchor" id="H1746687274"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Mortality from yersiniosis is relatively low. In one study including 458 patients in Norway, only two fatalities occurred during the acute phase of illness [<a href="#rid101">101</a>]. Similarly, among 1373 cases of yersiniosis in the United States between 1996 and 2007, 18 deaths (1.2 percent) were reported [<a href="#rid41">41</a>]. Of the cases identified, 30 percent were hospitalized and 3 percent had documented bacteremia.</p><p class="headingAnchor" id="H3907235115"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Measures to prevent <em>Yersinia</em> infection include: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food and animal safety </strong>– Basic tenets of food safety are important for prevention of yersiniosis [<a href="#rid102">102</a>]. These include safe food preparation and hand washing after exposure to pigs or raw pork products and avoiding cross-contamination, as well as avoiding consumption of raw or undercooked pork [<a href="#rid103">103</a>]. Important industrial interventions include careful hygiene at slaughter, as well as milk pasteurization and careful hygiene in dairy plants. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transfusion safety</strong> – Measures for prevention of transfusion-associated infection include testing packed red blood cells for presence of bacterial endotoxin and limiting the shelf-life of packed red cells. (See  <a class="medical medical_review" href="/d/html/3805.html" rel="external">"Transfusion-transmitted bacterial infection"</a>.)</p><p></p><p class="headingAnchor" id="H865563107"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Transmission </strong>– Transmission of yersiniosis is largely foodborne (including consumption of raw or undercooked pork, as well as other food sources) and occasionally waterborne. Uncommon modes of transmission include household pet exposure, person-to-person transmission, and blood transfusion. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Risk factors</strong> – Factors conferring increased risk for yersiniosis include age &lt;5 years of age, derangements of iron metabolism, and other comorbid conditions including immunosuppression. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Major clinical manifestations include enterocolitis and pseudoappendicitis. A variety of complications and post-infectious sequelae have also been described. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute yersiniosis</strong> – The typical incubation period is 4 to 6 days (range 1 to 14 days). Clinical manifestations include fever, abdominal pain, and diarrhea; nausea and vomiting may also occur. Bloody diarrhea is observed more frequently among children. Pharyngitis may be a presenting symptom. Bacteremia and sepsis can occur, particularly among infants and individuals with impaired immunity or iron-overload states. (See <a class="local">'Acute yersiniosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pseudoappendicitis</strong> – Acute yersiniosis may be confused with acute appendicitis; overlapping symptoms may include right lower quadrant abdominal pain, fever, vomiting, leukocytosis, and diarrhea. (See <a class="local">'Pseudoappendicitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Post-infectious sequelae</strong> – Post-infectious sequelae include erythema nodosum and reactive arthritis. (See <a class="local">'Post-infectious sequelae'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clinical suspicion</strong> – Yersiniosis should be suspected in the setting of relevant clinical manifestations (fever, abdominal pain, and diarrhea, with or without nausea and vomiting); these may occur in the presence or absence of relevant epidemiologic exposure (such as consumption of raw or undercooked pork or exposure to food or water implicated in an outbreak). (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnostic evaluation</strong> – Stool should be sent for culture; if available, stool may also be sent for rapid molecular panel testing. Patients with fever should have blood cultures obtained. Patients with pharyngitis should have throat culture obtained. For patients who undergo surgery in the setting of suspected appendicitis, operative specimens should be cultured. (See <a class="local">'Clinical approach'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Organism identification</strong> – The diagnosis of <em>Yersinia</em> infection is usually established by culture of the organism from stool or blood; it may also be established by culture from other sterile sites. Specimens that test positive by culture-independent tools should be set up for reflex culture to confirm the diagnosis and obtain antimicrobial susceptibility data. (See <a class="local">'Organism identification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of enterocolitis </strong>(See <a class="local">'Nonsevere enterocolitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications</strong> </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with mild enterocolitis in the absence of risk for severe illness, we suggest not treating with antibiotic therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>), given lack of demonstrated benefit. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For patients with nonsevere enterocolitis who are neonates, or have underlying immunosuppression or derangement of iron metabolism, we suggest treatment with oral antibiotic therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic selection and duration</strong> – For adults we treat with a fluoroquinolone (<a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> or <a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">levofloxacin</a>); alternative agents include <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> or <a class="drug drug_general" data-topicid="9393" href="/d/drug information/9393.html" rel="external">doxycycline</a>. For children we treat with trimethoprim-sulfamethoxazole. </p><p></p><p class="bulletIndent2">The usual treatment duration is five days.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment of severe illness</strong> (See <a class="local">'Severe illness'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications</strong> – For patients with bacteremia, sepsis, or severe illness (grossly bloody stools and high fever, other manifestations of extraintestinal infection), we suggest treatment with intravenous antibiotic therapy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic selection and duration</strong> – We favor treatment with <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> in combination with <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a>; <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> is an alternative agent to ceftriaxone. </p><p></p><p class="bulletIndent2">We treat for at least three weeks; a longer duration may be appropriate for patients with compromised immunity or focal extraintestinal infection. Once clinically improved, treatment may be completed with oral therapy. </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">McNally A, Thomson NR, Reuter S, Wren BW. 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution. Nat Rev Microbiol 2016; 14:177.</a></li><li><a class="nounderline abstract_t">Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10:257.</a></li><li><a class="nounderline abstract_t">Virtanen S, Nikunen S, Korkeala H. Introduction of infected animals to herds is an important route for the spread of Yersinia enterocolitica infection between pig farms. J Food Prot 2014; 77:116.</a></li><li><a class="nounderline abstract_t">de Boer E. Isolation of Yersinia enterocolitica from foods. Contrib Microbiol Immunol 1995; 13:71.</a></li><li><a class="nounderline abstract_t">Fredriksson-Ahomaa M, Hielm S, Korkeala H. High prevalence of yadA-positive Yersinia enterocolitica in pig tongues and minced meat at the retail level in Finland. J Food Prot 1999; 62:123.</a></li><li><a class="nounderline abstract_t">Wuthe HH, Aleksić S, Kwapil S. Yersinia in the European brown hare of northern Germany. Contrib Microbiol Immunol 1995; 13:51.</a></li><li><a class="nounderline abstract_t">Slee KJ, Skilbeck NW. Epidemiology of Yersinia pseudotuberculosis and Y. enterocolitica infections in sheep in Australia. J Clin Microbiol 1992; 30:712.</a></li><li><a class="nounderline abstract_t">Wilson PR. Advances in health and welfare of farmed deer in New Zealand. N Z Vet J 2002; 50:105.</a></li><li><a class="nounderline abstract_t">Wilson HD, McCormick JB, Feeley JC. Yersinia enterocolitica infection in a 4-month-old infant associated with infection in household dogs. J Pediatr 1976; 89:767.</a></li><li><a class="nounderline abstract_t">Morse DL, Shayegani M, Gallo RJ. Epidemiologic investigation of a Yersinia camp outbreak linked to a food handler. Am J Public Health 1984; 74:589.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Red blood cell transfusions contaminated with Yersinia enterocolitica--United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997; 46:553.</a></li><li><a class="nounderline abstract_t">Guinet F, Carniel E, Leclercq A. Transfusion-transmitted Yersinia enterocolitica sepsis. Clin Infect Dis 2011; 53:583.</a></li><li><a class="nounderline abstract_t">Tauxe RV, Vandepitte J, Wauters G, et al. Yersinia enterocolitica infections and pork: the missing link. Lancet 1987; 1:1129.</a></li><li><a class="nounderline abstract_t">Ostroff SM, Kapperud G, Hutwagner LC, et al. Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study. Epidemiol Infect 1994; 112:133.</a></li><li><a class="nounderline abstract_t">Thisted Lambertz S, Danielsson-Tham ML. Identification and characterization of pathogenic Yersinia enterocolitica isolates by PCR and pulsed-field gel electrophoresis. Appl Environ Microbiol 2005; 71:3674.</a></li><li><a class="nounderline abstract_t">Satterthwaite P, Pritchard K, Floyd D, Law B. A case-control study of Yersinia enterocolitica infections in Auckland. Aust N Z J Public Health 1999; 23:482.</a></li><li><a class="nounderline abstract_t">Lee LA, Taylor J, Carter GP, et al. Yersinia enterocolitica O:3: an emerging cause of pediatric gastroenteritis in the United States. The Yersinia enterocolitica Collaborative Study Group. J Infect Dis 1991; 163:660.</a></li><li><a class="nounderline abstract_t">Lee LA, Gerber AR, Lonsway DR, et al. Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings. N Engl J Med 1990; 322:984.</a></li><li><a class="nounderline abstract_t">Jones TF. From pig to pacifier: chitterling-associated yersiniosis outbreak among black infants. Emerg Infect Dis 2003; 9:1007.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Yersinia enterocolitica gastroenteritis among infants exposed to chitterlings--Chicago, Illinois, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:956.</a></li><li><a class="nounderline abstract_t">Tacket CO, Ballard J, Harris N, et al. An outbreak of Yersinia enterocolitica infections caused by contaminated tofu (soybean curd). Am J Epidemiol 1985; 121:705.</a></li><li><a class="nounderline abstract_t">Tacket CO, Narain JP, Sattin R, et al. A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk. JAMA 1984; 251:483.</a></li><li><a class="nounderline abstract_t">Ackers ML, Schoenfeld S, Markman J, et al. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk. J Infect Dis 2000; 181:1834.</a></li><li><a class="nounderline abstract_t">MacDonald E, Heier BT, Nygård K, et al. Yersinia enterocolitica outbreak associated with ready-to-eat salad mix, Norway, 2011. Emerg Infect Dis 2012; 18:1496.</a></li><li><a class="nounderline abstract_t">Longenberger AH, Gronostaj MP, Yee GY, et al. Yersinia enterocolitica infections associated with improperly pasteurized milk products: southwest Pennsylvania, March-August, 2011. Epidemiol Infect 2014; 142:1640.</a></li><li><a class="nounderline abstract_t">MacDonald E, Einöder-Moreno M, Borgen K, et al. National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014. Euro Surveill 2016; 21.</a></li><li><a class="nounderline abstract_t">Espenhain L, Riess M, Müller L, et al. Cross-border outbreak of Yersinia enterocolitica O3 associated with imported fresh spinach, Sweden and Denmark, March 2019. Euro Surveill 2019; 24.</a></li><li><a class="nounderline abstract_t">Kuehnert MJ, Roth VR, Haley NR, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41:1493.</a></li><li><a class="nounderline abstract_t">Nuorti JP, Niskanen T, Hallanvuo S, et al. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis 2004; 189:766.</a></li><li><a class="nounderline abstract_t">Niskanen T, Fredriksson-Ahomaa M, Korkeala H. Occurrence of Yersinia pseudotuberculosis in iceberg lettuce and environment. Adv Exp Med Biol 2003; 529:383.</a></li><li><a class="nounderline abstract_t">Nowgesic E, Fyfe M, Hockin J, et al. Outbreak of Yersinia pseudotuberculosis in British Columbia--November 1998. Can Commun Dis Rep 1999; 25:97.</a></li><li><a class="nounderline abstract_t">Rimhanen-Finne R, Niskanen T, Hallanvuo S, et al. Yersinia pseudotuberculosis causing a large outbreak associated with carrots in Finland, 2006. Epidemiol Infect 2009; 137:342.</a></li><li><a class="nounderline abstract_t">Williamson DA, Baines SL, Carter GP, et al. Genomic Insights into a Sustained National Outbreak of Yersinia pseudotuberculosis. Genome Biol Evol 2016; 8:3806.</a></li><li><a class="nounderline abstract_t">Adamkiewicz TV, Berkovitch M, Krishnan C, et al. Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors. Clin Infect Dis 1998; 27:1362.</a></li><li><a class="nounderline abstract_t">Ostroff S. Yersinia as an emerging infection: epidemiologic aspects of Yersiniosis. Contrib Microbiol Immunol 1995; 13:5.</a></li><li class="breakAll">European Centre for Disease Prevention and Control. Yersiniosis - Annual Epidemiological Report for 2016. https://ecdc.europa.eu/en/publications-data/yersiniosis-annual-epidemiological-report-2016 (Accessed on June 26, 2019).</li><li><a class="nounderline abstract_t">Verhaegen J, Charlier J, Lemmens P, et al. Surveillance of human Yersinia enterocolitica infections in Belgium: 1967-1996. Clin Infect Dis 1998; 27:59.</a></li><li><a class="nounderline abstract_t">Nesbakken T, Eckner K, Høidal HK, Røtterud OJ. Occurrence of Y. enterocolitica in slaughter pigs and consequences for meat inspection, slaughtering and dressing procedures. Adv Exp Med Biol 2003; 529:303.</a></li><li><a class="nounderline abstract_t">Delahoy MJ, Shah HJ, Weller DL, et al. Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022. MMWR Morb Mortal Wkly Rep 2023; 72:701.</a></li><li><a class="nounderline abstract_t">Tack DM, Marder EP, Griffin PM, et al. Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2015-2018. MMWR Morb Mortal Wkly Rep 2019; 68:369.</a></li><li><a class="nounderline abstract_t">Long C, Jones TF, Vugia DJ, et al. Yersinia pseudotuberculosis and Y. enterocolitica infections, FoodNet, 1996-2007. Emerg Infect Dis 2010; 16:566.</a></li><li><a class="nounderline abstract_t">Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis 2011; 17:7.</a></li><li><a class="nounderline abstract_t">Rivas L, Strydom H, Paine S, et al. Yersiniosis in New Zealand. Pathogens 2021; 10.</a></li><li><a class="nounderline abstract_t">Ong KL, Gould LH, Chen DL, et al. Changing epidemiology of Yersinia enterocolitica infections: markedly decreased rates in young black children, Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2009. Clin Infect Dis 2012; 54 Suppl 5:S385.</a></li><li><a class="nounderline abstract_t">Bottone EJ. Yersinia enterocolitica: Revisitation of an Enduring Human Pathogen. Clin Microbiol Newsletter 2015; 37:1.</a></li><li><a class="nounderline abstract_t">Adeolu M, Alnajar S, Naushad S, S Gupta R. Genome-based phylogeny and taxonomy of the 'Enterobacteriales': proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Int J Syst Evol Microbiol 2016; 66:5575.</a></li><li><a class="nounderline abstract_t">Wauters G, Kandolo K, Janssens M. Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol 1987; 9:14.</a></li><li class="breakAll">Tsubokura M. Yersinioses other than plague. In: Laboratory Diagnosis of Infectious Diseases, Balows A, Hausler WJ Jr, Ohashi M, Turano A (Eds), Springer-Verlag, New York City 1989. p.540.</li><li><a class="nounderline abstract_t">Lobato MJ, Landeras E, González-Hevia MA, Mendoza MC. Genetic heterogeneity of clinical strains of Yersinia enterocolitica traced by ribotyping and relationships between ribotypes, serotypes, and biotypes. J Clin Microbiol 1998; 36:3297.</a></li><li><a class="nounderline abstract_t">Carniel E, Mazigh D, Mollaret HH. Expression of iron-regulated proteins in Yersinia species and their relation to virulence. Infect Immun 1987; 55:277.</a></li><li><a class="nounderline abstract_t">Cherchi GB, Cossellu S, Pacifico L, et al. Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients. Contrib Microbiol Immunol 1995; 13:16.</a></li><li><a class="nounderline abstract_t">Burnens AP, Frey A, Nicolet J. Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease. Epidemiol Infect 1996; 116:27.</a></li><li><a class="nounderline abstract_t">van der Heijden IM, Res PC, Wilbrink B, et al. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin Infect Dis 1997; 25:831.</a></li><li><a class="nounderline abstract_t">Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med 1989; 321:16.</a></li><li><a class="nounderline abstract_t">El Qouqa IA, El Jarou MA, Samaha AS, et al. Yersinia enterocolitica infection among children aged less than 12 years: a case-control study. Int J Infect Dis 2011; 15:e48.</a></li><li><a class="nounderline abstract_t">Ostroff SM, Kapperud G, Lassen J, et al. Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis 1992; 166:812.</a></li><li><a class="nounderline abstract_t">Marks MI, Pai CH, Lafleur L, et al. Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr 1980; 96:26.</a></li><li><a class="nounderline abstract_t">Naqvi SH, Swierkosz EM, Gerard J, Mills JR. Presentation of Yersinia enterocolitica enteritis in children. Pediatr Infect Dis J 1993; 12:386.</a></li><li><a class="nounderline abstract_t">Feeney GF, Kerlin P, Sampson JA. Clinical aspects of infection with Yersinia enterocolitica in adults. Aust N Z J Med 1987; 17:216.</a></li><li class="breakAll">American Academy of Pediatrics. Yersinia enterocolitica and Yersinia pseudotuberculosis infections (Enteritis and other illnesses). In: Red Book: 2018 Report of the Committee on Infectious Diseases, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village 2018. p.891.</li><li><a class="nounderline abstract_t">Tacket CO, Davis BR, Carter GP, et al. Yersinia enterocolitica pharyngitis. Ann Intern Med 1983; 99:40.</a></li><li><a class="nounderline abstract_t">Amphlett A. Far East scarlet-like fever: A review of the epidemiology, symptomatology, and role of superantigenic toxin: Yersinia pseudotuberculosis-derived mitogen A. Open Forum Infect Dis 2016; 3:1.</a></li><li><a class="nounderline abstract_t">Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis 1993; 17:405.</a></li><li><a class="nounderline abstract_t">alMohsen I, Luedtke G, English BK. Invasive infections caused by Yersinia enterocolitica in infants. Pediatr Infect Dis J 1997; 16:253.</a></li><li><a class="nounderline abstract_t">Shorter NA, Thompson MD, Mooney DP, Modlin JF. Surgical aspects of an outbreak of Yersinia enterocolitis. Pediatr Surg Int 1998; 13:2.</a></li><li><a class="nounderline abstract_t">Black RE, Jackson RJ, Tsai T, et al. Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk. N Engl J Med 1978; 298:76.</a></li><li><a class="nounderline abstract_t">Niléhn B, Sjöström B. Studies on Yersinia enterocolitica. Occurrence in various groups of acute abdominal disease. Acta Pathol Microbiol Scand 1967; 71:612.</a></li><li><a class="nounderline abstract_t">Van Noyen R, Selderslaghs R, Bekaert J, et al. Causative role of Yersinia and other enteric pathogens in the appendicular syndrome. Eur J Clin Microbiol Infect Dis 1991; 10:735.</a></li><li><a class="nounderline abstract_t">Puylaert JB, Bodewes HW, Vermeijden RJ, et al. [Bacterial ileocecitis, a "new" disease]. Ned Tijdschr Geneeskd 1991; 135:2176.</a></li><li><a class="nounderline abstract_t">Black RE, Slome S. Yersinia enterocolitica. Infect Dis Clin North Am 1988; 2:625.</a></li><li><a class="nounderline abstract_t">Reed RP, Robins-Browne RM, Williams ML. Yersinia enterocolitica peritonitis. Clin Infect Dis 1997; 25:1468.</a></li><li><a class="nounderline abstract_t">Blinkhorn RJ Jr, Marino JA. Lateral pharyngeal abscess due to Yersinia enterocolitica. Am J Med 1988; 85:851.</a></li><li><a class="nounderline abstract_t">Krogstad P, Mendelman PM, Miller VL, et al. Clinical and microbiologic characteristics of cutaneous infection with Yersinia enterocolitica. J Infect Dis 1992; 165:740.</a></li><li><a class="nounderline abstract_t">Crowe M, Ashford K, Ispahani P. Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica. J Med Microbiol 1996; 45:302.</a></li><li><a class="nounderline abstract_t">Kellogg CM, Tarakji EA, Smith M, Brown PD. Bacteremia and suppurative lymphadenitis due to Yersinia enterocolitica in a neutropenic patient who prepared chitterlings. Clin Infect Dis 1995; 21:236.</a></li><li><a class="nounderline abstract_t">Jaspers CA, Begashaw K. Case report: an unusual presentation of Yersinia enterocolitica infection. Neth J Med 2001; 59:98.</a></li><li><a class="nounderline abstract_t">Leirisalo-Repo M. Yersinia arthritis. Acute clinical picture and long-term prognosis. Contrib Microbiol Immunol 1987; 9:145.</a></li><li><a class="nounderline abstract_t">Ahvonen P. Human yersiniosis in Finland. II. Clinical features. Ann Clin Res 1972; 4:39.</a></li><li><a class="nounderline abstract_t">Vasala M, Hallanvuo S, Ruuska P, et al. High frequency of reactive arthritis in adults after Yersinia pseudotuberculosis O:1 outbreak caused by contaminated grated carrots. Ann Rheum Dis 2014; 73:1793.</a></li><li><a class="nounderline abstract_t">Leirisalo-Repo M, Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum 1988; 31:533.</a></li><li><a class="nounderline abstract_t">Saari KM, Mäki M, Päivönsalo T, et al. Acute anterior uveitis and conjunctivitis following Yersinia infection in children. Int Ophthalmol 1986; 9:237.</a></li><li><a class="nounderline abstract_t">Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320:216.</a></li><li><a class="nounderline abstract_t">Granfors K, Merilahti-Palo R, Luukkainen R, et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998; 41:855.</a></li><li><a class="nounderline abstract_t">Shenkman L, Bottone EJ. Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med 1976; 85:735.</a></li><li class="breakAll">Yersinia enterocolitica and Yersinia pseudotuberculosis infections. Red Book: 2021-2024 Report of the Committee on Infectious Diseases (32nd Edition).</li><li><a class="nounderline abstract_t">Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:e45.</a></li><li><a class="nounderline abstract_t">Head CB, Whitty DA, Ratnam S. Comparative study of selective media for recovery of Yersinia enterocolitica. J Clin Microbiol 1982; 16:615.</a></li><li><a class="nounderline abstract_t">Renaud N, Lecci L, Courcol RJ, et al. CHROMagar Yersinia, a new chromogenic agar for screening of potentially pathogenic Yersinia enterocolitica isolates in stools. J Clin Microbiol 2013; 51:1184.</a></li><li><a class="nounderline abstract_t">Khare R, Espy MJ, Cebelinski E, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol 2014; 52:3667.</a></li><li><a class="nounderline abstract_t">Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:1963.</a></li><li><a class="nounderline abstract_t">Pham JN, Bell SM, Hardy MJ, et al. Comparison of beta-lactamase production by Yersinia enterocolitica biotype 4, serotype O:3 isolated in eleven countries. Contrib Microbiol Immunol 1995; 13:180.</a></li><li><a class="nounderline abstract_t">Preston M, Brown S, Borczyk A, et al. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990. Contrib Microbiol Immunol 1995; 13:175.</a></li><li><a class="nounderline abstract_t">Stolk-Engelaar V, Meis J, Mulder J, et al. Activity of 24 antimicrobials against Yersinia enterocolitica. Contrib Microbiol Immunol 1995; 13:172.</a></li><li><a class="nounderline abstract_t">Capilla S, Ruiz J, Goñi P, et al. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates. J Antimicrob Chemother 2004; 53:1068.</a></li><li><a class="nounderline abstract_t">Capilla S, Goñi P, Rubio MC, et al. Epidemiological study of resistance to nalidixic acid and other antibiotics in clinical Yersinia enterocolitica O:3 isolates. J Clin Microbiol 2003; 41:4876.</a></li><li><a class="nounderline abstract_t">Pai CH, Gillis F, Tuomanen E, Marks MI. Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatr 1984; 104:308.</a></li><li><a class="nounderline abstract_t">Sato K, Ouchi K, Komazawa M. Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children. Pediatr Infect Dis J 1988; 7:686.</a></li><li><a class="nounderline abstract_t">Frydén A, Bengtsson A, Foberg U, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 1990; 301:1299.</a></li><li><a class="nounderline abstract_t">Press N, Fyfe M, Bowie W, Kelly M. Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib. Scand J Infect Dis 2001; 33:523.</a></li><li><a class="nounderline abstract_t">Jackson MA, Schutze GE, COMMITTEE ON INFECTIOUS DISEASES. The Use of Systemic and Topical Fluoroquinolones. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Saebø A, Lassen J. Survival and causes of death among patients with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients. Scand J Infect Dis 1992; 24:613.</a></li><li class="breakAll">www.foodsafety.gov (Accessed on September 15, 2023).</li><li><a class="nounderline abstract_t">Rosner BM, Stark K, Höhle M, Werber D. Risk factors for sporadic Yersinia enterocolitica infections, Germany 2009-2010. Epidemiol Infect 2012; 140:1738.</a></li></ol></div><div id="topicVersionRevision">Topic 3139 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26876035" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9105754" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Yersinia enterocolitica: the charisma continues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24406008" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Introduction of infected animals to herds is an important route for the spread of Yersinia enterocolitica infection between pig farms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833800" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Isolation of Yersinia enterocolitica from foods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10030629" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : High prevalence of yadA-positive Yersinia enterocolitica in pig tongues and minced meat at the retail level in Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833795" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Yersinia in the European brown hare of northern Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1313049" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Epidemiology of Yersinia pseudotuberculosis and Y. enterocolitica infections in sheep in Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16032253" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Advances in health and welfare of farmed deer in New Zealand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/978324" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Yersinia enterocolitica infection in a 4-month-old infant associated with infection in household dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6721015" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Epidemiologic investigation of a Yersinia camp outbreak linked to a food handler.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9221323" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Red blood cell transfusions contaminated with Yersinia enterocolitica--United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21865196" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Transfusion-transmitted Yersinia enterocolitica sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2883453" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Yersinia enterocolitica infections and pork: the missing link.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8119353" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16000776" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Identification and characterization of pathogenic Yersinia enterocolitica isolates by PCR and pulsed-field gel electrophoresis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10575769" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A case-control study of Yersinia enterocolitica infections in Auckland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1995741" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Yersinia enterocolitica O:3: an emerging cause of pediatric gastroenteritis in the United States. The Yersinia enterocolitica Collaborative Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2314448" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Yersinia enterocolitica O:3 infections in infants and children, associated with the household preparation of chitterlings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12967503" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : From pig to pacifier: chitterling-associated yersiniosis outbreak among black infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14534510" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Yersinia enterocolitica gastroenteritis among infants exposed to chitterlings--Chicago, Illinois, 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4014162" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : An outbreak of Yersinia enterocolitica infections caused by contaminated tofu (soybean curd).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6546313" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10823796" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22932318" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Yersinia enterocolitica outbreak associated with ready-to-eat salad mix, Norway, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24128938" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Yersinia enterocolitica infections associated with improperly pasteurized milk products: southwest Pennsylvania, March-August, 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27588690" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31213223" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cross-border outbreak of Yersinia enterocolitica O3 associated with imported fresh spinach, Sweden and Denmark, March 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11778062" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14976592" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756795" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Occurrence of Yersinia pseudotuberculosis in iceberg lettuce and environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10726370" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Outbreak of Yersinia pseudotuberculosis in British Columbia--November 1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18177523" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Yersinia pseudotuberculosis causing a large outbreak associated with carrots in Finland, 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28173076" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Genomic Insights into a Sustained National Outbreak of Yersinia pseudotuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9868642" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833784" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Yersinia as an emerging infection: epidemiologic aspects of Yersiniosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833784" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Yersinia as an emerging infection: epidemiologic aspects of Yersiniosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9675452" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Surveillance of human Yersinia enterocolitica infections in Belgium: 1967-1996.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756775" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Occurrence of Y. enterocolitica in slaughter pigs and consequences for meat inspection, slaughtering and dressing procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37384552" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31022166" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2015-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20202449" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Yersinia pseudotuberculosis and Y. enterocolitica infections, FoodNet, 1996-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21192848" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Foodborne illness acquired in the United States--major pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33578727" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Yersiniosis in New Zealand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572658" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Changing epidemiology of Yersinia enterocolitica infections: markedly decreased rates in young black children, Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Yersinia enterocolitica: Revisitation of an Enduring Human Pathogen</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27620848" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Genome-based phylogeny and taxonomy of the 'Enterobacteriales': proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3665492" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Revised biogrouping scheme of Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3665492" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Revised biogrouping scheme of Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9774582" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Genetic heterogeneity of clinical strains of Yersinia enterocolitica traced by ribotyping and relationships between ribotypes, serotypes, and biotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3793233" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Expression of iron-regulated proteins in Yersinia species and their relation to virulence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833786" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8626001" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9356797" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Yersinia enterocolitica: a cause of chronic polyarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2659991" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21131221" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Yersinia enterocolitica infection among children aged less than 12 years: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1527416" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Clinical features of sporadic Yersinia enterocolitica infections in Norway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7350311" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8327299" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Presentation of Yersinia enterocolitica enteritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3304248" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Clinical aspects of infection with Yersinia enterocolitica in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3304248" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Clinical aspects of infection with Yersinia enterocolitica in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6687988" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Yersinia enterocolitica pharyngitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Far East scarlet-like fever: A review of the epidemiology, symptomatology, and role of superantigenic toxin: Yersinia pseudotuberculosis-derived mitogen A</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8218681" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9041613" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Invasive infections caused by Yersinia enterocolitica in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9391192" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Surgical aspects of an outbreak of Yersinia enterocolitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/579433" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5584519" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Studies on Yersinia enterocolitica. Occurrence in various groups of acute abdominal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1810725" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Causative role of Yersinia and other enteric pathogens in the appendicular syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1956444" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : [Bacterial ileocecitis, a "new" disease].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3074119" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9431397" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Yersinia enterocolitica peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3195607" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Lateral pharyngeal abscess due to Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1552204" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Clinical and microbiologic characteristics of cutaneous infection with Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8849705" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7578750" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Bacteremia and suppurative lymphadenitis due to Yersinia enterocolitica in a neutropenic patient who prepared chitterlings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11583824" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Case report: an unusual presentation of Yersinia enterocolitica infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3311632" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Yersinia arthritis. Acute clinical picture and long-term prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5020658" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Human yersiniosis in Finland. II. Clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23852698" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : High frequency of reactive arthritis in adults after Yersinia pseudotuberculosis O:1 outbreak caused by contaminated grated carrots.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2965876" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Ten-year follow-up study of patients with Yersinia arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3539842" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Acute anterior uveitis and conjunctivitis following Yersinia infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2643047" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Yersinia antigens in synovial-fluid cells from patients with reactive arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9588737" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1036668" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Antibodies to Yersinia enterocolitica in thyroid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1036668" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Antibodies to Yersinia enterocolitica in thyroid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29053792" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7153309" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Comparative study of selective media for recovery of Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23363840" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : CHROMagar Yersinia, a new chromogenic agar for screening of potentially pathogenic Yersinia enterocolitica isolates in stools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25100818" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29194529" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833828" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Comparison of beta-lactamase production by Yersinia enterocolitica biotype 4, serotype O:3 isolated in eleven countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833827" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833826" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Activity of 24 antimicrobials against Yersinia enterocolitica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15117921" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14532248" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Epidemiological study of resistance to nalidixic acid and other antibiotics in clinical Yersinia enterocolitica O:3 isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6363661" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3054777" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2271852" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11515763" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940800" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The Use of Systemic and Topical Fluoroquinolones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1465579" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Survival and causes of death among patients with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1465579" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Survival and causes of death among patients with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22313798" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Risk factors for sporadic Yersinia enterocolitica infections, Germany 2009-2010.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
